Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Efficient protocols to differentiate human pluripotent stem cells to various tissues in combination with -omics technologies opened up new horizons for in vitro toxicity testing of potential drugs. To provide a solid scientific basis for such assays, it will be important to gain quantitative informa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of visualized experiments 2015-06 (100), p.e52333-e52333
Main Authors: Shinde, Vaibhav, Klima, Stefanie, Sureshkumar, Perumal Srinivasan, Meganathan, Kesavan, Jagtap, Smita, Rempel, Eugen, Rahnenführer, Jörg, Hengstler, Jan Georg, Waldmann, Tanja, Hescheler, Jürgen, Leist, Marcel, Sachinidis, Agapios
Format: Article
Language:English
Subjects:
Animal Testing Alternatives - methods
Developmental Biology
Humans
Pluripotent Stem Cells - drug effects
Systems Biology - methods
Toxicity Tests - methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efficient protocols to differentiate human pluripotent stem cells to various tissues in combination with -omics technologies opened up new horizons for in vitro toxicity testing of potential drugs. To provide a solid scientific basis for such assays, it will be important to gain quantitative information on the time course of development and on the underlying regulatory mechanisms by systems biology approaches. Two assays have therefore been tuned here for these requirements. In the UKK test system, human embryonic stem cells (hESC) (or other pluripotent cells) are left to spontaneously differentiate for 14 days in embryoid bodies, to allow generation of cells of all three germ layers. This system recapitulates key steps of early human embryonic development, and it can predict human-specific early embryonic toxicity/teratogenicity, if cells are exposed to chemicals during differentiation. The UKN1 test system is based on hESC differentiating to a population of neuroectodermal progenitor (NEP) cells for 6 days. This system recapitulates early neural development and predicts early developmental neurotoxicity and epigenetic changes triggered by chemicals. Both systems, in combination with transcriptome microarray studies, are suitable for identifying toxicity biomarkers. Moreover, they may be used in combination to generate input data for systems biology analysis. These test systems have advantages over the traditional toxicological studies requiring large amounts of animals. The test systems may contribute to a reduction of the costs for drug development and chemical safety evaluation. Their combination sheds light especially on compounds that may influence neurodevelopment specifically.
ISSN:1940-087X
1940-087X
DOI:10.3791/52333